Zhang J X, Bauer M, Clemens M G
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Am J Physiol. 1995 Aug;269(2 Pt 1):G269-77. doi: 10.1152/ajpgi.1995.269.2.G269.
We studied the sinusoidal and extrasinusoidal constrictor response of hepatic microcirculation to endothelin-1 (ET-1) and endothelin-3 (ET-3) and the possible role of Ito cells vs. Kupffer cells or endothelial cells in mediating this response, using isolated rat livers under high-power intravital microscopy. Rats were pretreated by injection of 2.6 x 10(8) fluorescent latex beads (1 micron) intravenously to label Kupffer cells. Three hours later livers were isolated and perfused before and during the infusion of 1 nM ET-1 or ET-3 with or without the endothelin type A (ETA) receptor antagonist BQ-123 or ETB antagonist IRL-1038. Alternatively, the perfused livers were infused with the ETB agonist sarafotoxin 6c (S6c, 1 or 5 nM). Sinusoid diameters were quantitated at the sites of Ito cells (identified by vitamin A fluorescence) or Kupffer cells (phagocytosed fluorescent latex beads) or where neither cell type was found (endothelial cells). ET-1 was found to induce significant sinusoid constriction at the sites of Ito cells (13.21 +/- 0.58 microns control vs. 10.47 +/- 0.48 microns during ET-1 infusion) but not at the sites of Kupffer cells or endothelial cells (13.26 +/- 0.79 vs. 12.92 +/- 0.61 microns and 12.20 +/- 0.71 vs. 11.98 +/- 0.40 microns, respectively), whereas neither ET-3 nor S6c had any effect on sinusoid narrowing, despite a 1.8-fold (ET-3) or 5.6-fold (5 nM S6c) greater increase in total portal resistance compared with ET-1.(ABSTRACT TRUNCATED AT 250 WORDS)
我们使用高倍活体显微镜下的离体大鼠肝脏,研究了肝微循环对内皮素-1(ET-1)和内皮素-3(ET-3)的窦性和窦外收缩反应,以及贮脂细胞与库普弗细胞或内皮细胞在介导这种反应中可能的作用。通过静脉注射2.6×10⁸个荧光乳胶珠(1微米)对大鼠进行预处理,以标记库普弗细胞。三小时后分离肝脏并进行灌注,在输注1 nM ET-1或ET-3期间,无论有无内皮素A型(ETA)受体拮抗剂BQ-123或ETB拮抗剂IRL-1038。或者,向灌注的肝脏中输注ETB激动剂沙拉毒素6c(S6c,1或5 nM)。在贮脂细胞(通过维生素A荧光识别)、库普弗细胞(吞噬荧光乳胶珠)所在部位或未发现这两种细胞类型的部位(内皮细胞)对窦状隙直径进行定量。发现ET-1在贮脂细胞部位可诱导明显的窦状隙收缩(对照时为13.21±0.58微米,ET-1输注期间为10.47±0.48微米),但在库普弗细胞或内皮细胞部位则无此作用(分别为13.26±0.79对12.92±0.61微米和12.20±0.71对11.98±0.40微米),而ET-3和S6c对窦状隙变窄均无任何影响,尽管与ET-1相比,总门静脉阻力分别增加了1.8倍(ET-3)或5.6倍(5 nM S6c)。(摘要截短至250字)